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ABSTRACT
A novel method based on emulsion/filtration is
introduced for G-quadruplex DNA structural separ-
ation. We first synthesized a lipophilic analogue
of BMVC, 3,6-Bis(1-methyl-4-vinylpyridinium)-9-
(120-bromododecyl) carbazole diiodide (BMVC-
12C-Br), which can form an oil-in-water (o/w)
phase emulsion. Due to the binding preferences
of BMVC-12C-Br emulsion to some specific DNA
structures, the large emulsion ( 2mm) bound DNA
was separated from the small free DNA in the
filtrate by a 0.22mm pore size MCE membrane.
This method is able to isolate the non-parallel
G-quadruplexes from the parallel G-quadruplexes
and the linear duplexes from both G-quadruplexes.
In addition, this method allows us not only to deter-
mine the absence of the parallel G-quadruplexes
of d(T2AG3)4 and the presence of the parallel
G-quadruplexes of d(T2AG3)2 in K
+ solution, but
also to verify structural conversion from antiparallel
to parallel G-quadruplexes of d[AG3(T2AG3)3]i n
K
+ solution under molecular PEG condition.
Moreover, this emulsion can separate the non-
parallel G-quadruplexes of d(G3CGCG3AGGAAG5
CG3) monomer from the parallel G-quadruplexes of
its dimer in K
+solution. Together with NMR spectra,
one can simplify the spectra for both the free DNA
and the bound DNA to establish
a spectrum-structure correlation for further
structural analysis.
INTRODUCTION
A large number of guanine rich DNA sequences found in
the human genome can readily form G-quadruplex (G4)
structures (1–3). Recently, the biological implications of
G-quadruplexes in telomeres and gene promoter regions
have attracted much attention (4–8). Human telomere
contains thousands of hexameric repeated TTAGGG/
CCCTAA duplexes and a 100–200nt single-stranded
G-rich 30-overhang. Of interest is that this single-stranded
G-rich sequence can adopt G4 structures under certain
physiological conditions. Given that the majority of
cancers cause telomerase activation for telomere length
maintenance (9) and the G4 structure is not a template
for telomerase (10), such a structure has potential in the
development of telomerase inhibitors and anti-cancer
agents (11–14).
In the human BCL-2 (B-cell/lymphoma-2) gene
promoter region, Hurley et al. (15) found that the
middle four consecutive G-tracts of the BCL-2 gene
promoter, (G3CGCG3AGGAAG5CG3) (bcl2mid), is
likely to form the G4 structure in K
+ solution. BCL-2 is
an oncoprotein that plays an essential role in regulating
apoptosis. Aberrantly overexpressed BCL-2 is found in
a number of human cancers, such as B-cell and T-cell
lymphomas (16), breast (17), prostate (18), cervical (19),
colorectal (20) and lung carcinoma (21). The control of
BCL-2 expression provides a promising approach to
cancer treatment (22–24), because the G4 structure may
act as steric block to the transcription machinery.
G-quadruplexes are an attractive subject for research,
not only because of their relevance to the development
of new anti-cancer drugs but also to explore their potential
biological roles (25–27).
The G-rich sequences can form a variety of structures
and may coexist in mixtures. For example, NMR analysis
shows that the human telomeric sequence, AG3(T2AG3)3
(HT22), forms an antiparallel basket G4 structure in
Na
+ solution (28), while X-ray crystallography shows
that HT22 forms a parallel propeller G4 structure in the
presence of K
+ (29). NMR results also suggest the
presence of multiple conformers of HT22 in K
+ solution,
which poses a problem for structural analysis (30).
Although the propeller G4 structure is not a major
structure in K
+ solution, the predominant non-parallel
G4 structures in K
+ solution convert to the parallel G4
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Similarly, NMR studies suggest the presence of multiple
conformers of bcl2mid in K
+ solution (32).
Recently, gel assays have revealed that a major compo-
nent of the bcl2mid monomer exists at low [K
+] and
an additional dimer component appears at high [K
+].
The CD spectra show both 265nm and 295nm CD
bands of bcl2mid in 5mM K
+ solution and a strong CD
band at 265nm together with a weak CD band at 295nm
in 150mM K
+ solution (33). This demonstrates that
the major G4 structure of the bcl2mid monomer is the
non-parallel form and the major G4 structure of the
bcl2mid dimer is the parallel form. Structural conversion,
from the monomer to the dimer, depends upon the
annealing temperature, with respect to the melting
temperature, which increases as a function of K
+concen-
tration. The high complexity of various G4 structures,
under different solution conditions, makes structural
analysis even more difﬁcult. Development of a new
method for separating the various species present in
solution, for further individual study, is of critical
importance to the G4 research community.
Previously reported small molecule, 3,6-Bis(1-methyl-4-
vinylpyridinium) carbazole diiodide (BMVC) is not only
a G4 stabilizer (34), but also a ﬂuorescence probe
with higher binding afﬁnity to quadruplex than to
duplex DNA (35). Taking these advantageous properties
of BMVC into account, a new molecule 3,6-Bis(1-
methyl-4-vinylpyridinium)-9-(120-bromododecyl) carbazole
(BMVC-12C-Br) was synthesized by substituting a
dodecyl chain at 9-position of BMVC. Due to the hydro-
phobic moiety of the alkyl chain, this derivative acts as
a surfactant between oil and water. After ultrasonic emul-
siﬁcation, an oil-in-water (o/w) emulsion is formed (36).
The larger size of the  2mm of BMVC-12C-Br emulsion
than the 0.22mm pore size of mixed cellulose esters
(MCEs) membrane, together with the binding preference
of BMVC-12C-Br emulsion for parallel G4 structures
as different from non-parallel G4 structures and DNA
duplexes, allows us to demonstrate, for the ﬁrst time,
that the emulsiﬁed BMVC-12C-Br can be used to
separate different DNA structures after ﬁltration (37).
Table 1 lists the DNA sequences studied in this work.
EXPERIMENTAL
Synthesis of BMVC-12C-Br molecule
Synthesis of the BMVC-12C-Br molecule is brieﬂy
described in Scheme 1. One gram of 3,6-dibromocarbazole
(1, ACROS Co.) coupled with 1.5g 1,12-
dibromododecane (ACROS Co.) in the presence of
0.15g sodium hydride gave excellent yields (92–98%)
of 9-alkylcarbazoles (38). The reactions occurred at
room temperature for 12h in THF. The product,
3,6-dibromo-9-(120-bromododecyl) carbazole (2), was
extracted using ethyl acetate and recrystallized using
methanol. According to the Heck reaction (39),
1g compound 2 can couple with 4-vinylpyridine
Scheme 1. Synthesis of the BMVC-12C-Br molecule.
Table 1. The DNA sequences studied in this work
DNA name Sequence DNA name Sequence
HT24 (T2AG3)4 LD16 ATGCGCAATTGCGCAT
HT22 AG3(T2AG3)3 T3 G3(TG3)3
HT12 TAG3T2AG3T Bcl2mid G3CGCG3AGGAAG5CG3
Tel24-M T2G3(T2AG3)3A Bcl2mid-M G3CGCG3AGGAATTG3CG3
Tel19-M (TAG3)2TG3TAG3 Myc-2345 TGAG3TG4AG3TG4AA
Pu24myc TGAG3TG4AG3TG4A2G2 TBA15 G2T2G2TGTG2T2G2
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acetate (5mg, Strem) and tri-o-tolyl phosphine (50mg,
Aldrich) under the triethylamine (3ml)/tetrahydrofuran
(9ml) solvent pairs in a high pressure bottle at
105 C for 48h. The ﬂuorescent compound 3,6-bis(4-
vinylpyridinium)-9-(120-bromododecyl) carbazole (3) was
collected and recrystallized using n-hexane with a 20%
yield. After reﬂuxing compound 3 with excess CH3Ii n
Acetone/DMF for 12h, the orange powder,
3,6-Bis(1-methyl-4-vinylpyridinium)-9-(120-bromodod-
ecyl) carbazole diiodide (4) (BMVC-12C-Br), was col-
lected with a 60% yield after recrystallization twice
using methanol.
NMR data
1H NMR (d6-DMSO, 400MHz): d 8.82 (d, J=6.4Hz,
4H), 8.63 (s, 2H), 8.22 (d, J=16Hz, 4H), 8.21
(d, J=6.8Hz, 2H), 7.94 (d, J=8.8Hz, 2H), 7.79
(d, J=8.8Hz, 2H), 7.57 (d, J=16Hz, 2H), 4.48
(t, J=6.4Hz, 2H), 4.25 (s, 6H), 3.07 (m, J=8.4Hz,
2H), 1.80 (m, J=6.4Hz, 2H), 1.54 (m, J=6.4Hz, 2H),
1.13 (m, J=6.4Hz, 16H).
13C NMR (d6-DMSO, 400MHz): d (ppm) 153.59,
145.54, 142.63, 127.78, 127.54, 123.63, 123.35, 121.95,
121.29, 111.39, 56.69, 52.65, 47.45, 43.55, 29.67, 29.62,
29.55, 29.49, 29.31, 29.16, 27.13, 26.46, 21.59.
Chemical and sample preparation
All oligonucleotides were purchased from Bio Basic Inc.
and used without further puriﬁcation. Solutions of 10mM
Tris–HCl (pH 7.5) and 150mM NaCl (or KCl) mixed with
each DNA were heated to 95 C for 10min, cooled slowly
to room temperature and then stored overnight at
4 C before use.
Absorption, ﬂuorescence and circular dichroism
Absorption spectra were obtained using a UV-visible spec-
trophotometer (HELIOS a, Thermo Fisher Scientiﬁc,
USA), and ﬂuorescence spectra were recorded on a
spectroﬂuorometer (LS-55, PerkinElmer, USA) using a
2-nm band-pass in a 0.1-cm cell length at room tempera-
ture. Ten circular dichroism (CD) spectra were obtained
using a J-715 spectropolarimeter (Jasco, UK) and an
average was taken. A 2nm bandwidth, a scan speed of
50nm/min and a step resolution of 0.2nm were used.
The CD spectra were measured under N2 over the range
of 210–350nm to ascertain the G4 structures.
PAGE
The PAGE was conducted using 20% polyacrylamide
gels. Electrophoresis of the gels was carried out at
250V/cm for 4h at 4 C. After photography with UV
shadowing, the gels were post-stained using 20mMo f
BMVC for 30s at room temperature, and then rinsed
with distilled water. They were then photographed under
UV light at 254nm using a digital camera. The ﬂuores-
cence images of the gels were recorded in a FluoChem
HD2 (Alpha Innotech, USA). The relative quantities of
the major components in each lane were then measured
using an Alphaview program.
CARS and ﬂuorescence microscopic images
The optical setup for CARS microscopy can be found
elsewhere (40). Two Ti-sapphire lasers were used to
generate CARS and 2PE ﬂuorescence signals simultan-
eously. A 2.5 ps pulsed laser with a wavelength of
706nm served as the pump/probe beam for CARS,
while a 200 fs pulsed laser with a wavelength of
883.5nm served as the Stokes beam for CARS and 2PE.
The forward CARS scattering signal of the lipid C–H
stretching mode at  2845cm
 1 was collected at
 588nm. The 2PE ﬂuorescence signal from BMVC
moieties was collected by epi-detection.
Imino proton NMR
Experiments were performed using 800MHz Bruker spec-
trometers at 25 C. 1D NMR spectra were measured in
H2O/D2O (90%/10%) using a jump and return sequence
for solvent suppression. Strand concentration was
0.1mM; the solution contained 10mM Tris–HCl (pH
7.5) with a suitable salt condition, external with reference
DSS (41).
Analytical ultracentrifugation
Sedimentation experiments were performed using a
Beckman Optima XLA analytical ultracentrifuge.
Sedimentation velocity experiments of 0.5 OD DNA at
260nm were conducted at 20 C using a rotor speed of
60000rpm. Data analysis was carried out with the
program Sedﬁt (42).
RESULTS AND DISCUSSION
Fluorescence quantum yield and binding afﬁnity
We ﬁrst investigated if the BMVC-12C-Br molecule
maintains its ﬂuorescence and then determined its
binding preference to different DNA. Figure 1a shows
the absorption and ﬂuorescence spectra of free BMVC-
12C-Br and its complexes with DNA of LD16, HT24,
T3 and bcl2mid. The molar ratio of BMVC-12C-Br to
each DNA structure is 1:1 with a concentration of
20mM. The absorption band showed red shift upon
interaction with DNA. The molar absorption coefﬁcient
was decreased by 10–15% for LD16 and HT24 and
30–35% for bcl2mid and T3.
The ﬂuorescence of the free BMVC-12C-Br was quite
weak, but the ﬂuorescence increased by at least one order
of magnitude upon interaction with these DNA. The
ﬂuorescence quantum yield of BMVC-12C-Br is DNA
dependent. It was  0.38 for LD16,  0.3 for HT24,
 0.12 for T3 and  0.16 for bcl2mid. These different ﬂuor-
escence yields for BMVC-12C-Br are probably due to
the different binding interactions with the various DNA.
Such ﬂuorescence enhancements have been previously
observed for BMVC (34).
Figure 1b shows the gel competition assays for the
evaluation of the binding preferences of BMVC-12C-Br
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tion of ﬂuorescence from these BMVC-12C-Br bound
DNA indicates that BMVC-12C-Br can bind to these
DNA. Since the ﬂuorescence was not detected in LD16
in the competition assays, it is suggested that the
BMVC-12C-Br has a binding preference for HT24
and T3 over LD16. It is interesting to note that the
BMVC-12C-Br bound HT24 complex migrated faster
than the free HT24, whereas the BMVC-12C-Br bound
T3 complex migrated slower than the free T3. Together
with their distinct emissions, these results suggest that
BMVC-12C-Br has different binding sites in HT24
and T3 DNA.
Further ﬂuorescence titration was carried out to
measure the binding afﬁnities of BMVC-12C-Br to
LD16, T3 and HT24. Figure 2 shows the ﬂuorescence
spectra of 10mM of BMVC-12C-Br by adding DNA
from 0.25mMt o8 mM. The ﬂuorescence intensity used
to construct the binding plots of   versus Cf is shown in
the inset. The binding ratio   is deﬁned as Cb/CDNA,
where Cf, Cb and CDNA are the molar concentrations
of free ligand, bound ligand and DNA, respectively.
The difference between Ct and Cb gives the magnitude
of Cf, where Ct is the total concentration of ligand.
Binding parameters can be obtained by ﬁtting the plots
with using a multiple-equivalent-site model (43):
  ¼ nKCf=ð1+KCfÞ,
where K is the equilibrium binding constant, and n repre-
sents the average number of ligands bound per each DNA
structure. Note that this equation is identical to the
Scatchard equation,  /Cf=K(n  ). Using the binding
plots of   versus Cf, the problem of obtaining K and
n values from slightly nonlinear Scatchard plots becomes
irrelevant (44). Here, the binding parameters are measured
to be K 4.01 10
6 with n 4 to LD16, K 2.23 10
7
with n 1.9 to T3, and K 1.42 10
7 with n 3.1 to
HT24. These results suggest no positive correlation
between the ﬂuorescence quantum yield and the binding
afﬁnity of BMVC-12C-Br to these DNA.
Emulsiﬁcation
Since BMVC can be regarded as a hydrophilic site and
a 12-carbon chain can act as a hydrophobic site,
BMVC-12C-Br can form an oil-in-water (o/w) emulsion
by ultrasonic emulsiﬁcation (36). The emulsiﬁcation
of BMVC-12C-Br was achieved by adding a 0.1ml
squalane (ACROS Co.) to a 0.9ml of 1mM BMVC-
12C-Br water solution. The mixed solution was subjected
to ultrasound for 15min using an ultrasonic wave with
frequency (46kHz) and power (50W). The turbid
solution was stored in the dark for 2 weeks. The formation
of BMVC-12C-Br emulsion was conﬁrmed by coherent
anti-Stokes Raman scattering (CARS) and two-photon
excitation (2PE) ﬂuorescence microscopy. The overlap of
CARS and two-photon ﬂuorescence signals indicates the
formation of o/w phase emulsion particles, as shown in
Figure 3 (a and b). Here CARS (forward) and two-photon
ﬂuorescence (epi) signals were collected simultaneously.
The CARS signal at 2845cm
 1 is mainly due to the
C–H vibrational mode of the squalane located in the
center of the emulsion particles. The two-photon excited
ﬂuorescence signals from BMVC-12C-Br are mostly
distributed on the surface of the emulsion particles.
By changing the polarization of the laser pulses, the
brightest ﬂuorescence pattern was always aligned with
the laser polarization, as shown in Figure 3 (c and d),
mainly due to the parallel alignment of the BMVC-
12C-Br dipole and the laser polarization. The distinct
ﬂuorescence pattern of the BMVC-12C-Br emulsion
suggests that the BMVC moieties are arranged in an
orderly fashion on the surface of emulsion particles
(45,46).
Separation of G-quadruplex from linear duplex
In order to investigate whether this emulsion could
separate HT24 from LD16, we ﬁrst mixed 20mM
BMVC-12C-Br emulsion with 20mM each of HT24 and
LD16 in 150mM Na
+ solution for 5min and then
collected the ﬁltrate through a MCE membrane (0.22mm
pore size, Millipore). After ﬁltration, the emulsion was
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Figure 1. (a) The absorption and ﬂuorescence spectra of BMVC-12C-Br molecule and its complexes with various DNAs. (b) Gel assays of each
0.2nmol HT24 (Lane 1), T3 (Lane 2), LD16 (Lane 3), the mixtures of HT24 and T3 (Lane 4), HT24 and LD16 (Lane 5) and T3 and LD16 (Lane 6)
incubated with 0.2nmol BMVC-12C-Br.
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membrane while the ﬁltrate was clear and transparent.
Figure 4a shows the CD spectra before and after six
sequences of emulsion-induced ﬁltration (EIF). A discern-
ible decrease in the 295nm CD signal was detected after
each EIF. This change was not observed in the ﬁltrate
from the HT24/LD16 mixture without emulsion.
Figure 4b shows the spectral difference between the CD
spectra before ﬁltration and after the ﬁnal EIF. The CD
pattern for the spectral difference is quite similar to the
CD pattern for HT24, implying the loss of the HT24
component after EIF. In addition, the CD pattern
observed after the ﬁnal EIF is very similar to the CD
pattern for LD16, as shown in Figure 4b. It appears
that the BMVC-12C-Br emulsion has a high-binding
preference for G-quadruplex HT24 over duplex LD16.
We further investigated whether BMVC-12C-Br
emulsion could be used to separate different G4
structures. Figure 4c shows the CD spectra for equal
amounts of two well characterized G4 structures; an
antiparallel basket G4 structure of HT24 (28) and a
parallel propeller G4 structure of (G3TG3TG3TG3) (T3)
(47), mixed in 150mM Na
+solution before and after two
sequences of EIF. The spectral difference between the ﬁnal
and initial spectra is almost identical to the CD spectrum
of T3, as shown in the inset of Figure 4c. It appears that
BMVC-12C-Br emulsion has better binding ability to
the parallel G4 structure of T3 than the antiparallel G4
structure of HT24.
Gel assays were performed on the HT24/T3 mixture
before and after two sequences of EIF and staining
by BMVC. The stained gels were put into a FluoChem
HD2 and the ﬂuorescence images were recorded, as
shown in Figure 4d. Since the ﬂuorescence yield of
BMVC is DNA dependent (34), different staining
efﬁciencies are evident for HT24 and T3 in Figure 4d.
Nevertheless, the intensity change for each DNA after
each EIF can be estimated independently. The results
show a large decrease in the T3 component, but only
a slight change in the HT24 component after EIF.
Analysis of the 73% loss and 27% loss of the 265nm
CD band shows good correlation with the 68% loss and
29% loss of the T3 component in the gel assays after
the ﬁrst and the second sequences of EIF, respectively.
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Figure 2. Fluorescence titration of 10mM BMVC-12C-Br by adding
LD (a), T3 (b), and HT24 (c) from 0.25 to 8mMi nN a
+ solution.
Figure 3. The microscopic images of CARS signals at 2845cm
 1 C–H
vibrational mode of the squalane inside the emulsion particles (a) and
2PE ﬂuorescence signals from BMVC-12C-Br mainly on the surface of
the emulsion particles (b–d). The images (a) and (b) were collected
simultaneously.
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(blue) and Figure 4c (blue), are very similar to each other,
indicating that BMVC-12C-Br emulsion can effectively
bind to the parallel G4 structure of T3 and therefore
isolate the antiparallel G4 structure of HT24 from the
conformational mixture. To our knowledge, this is the
ﬁrst demonstration of the isolation of speciﬁc G4
structure.
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Figure 4. (a) CD spectra of 20mM HT24 and 20mM LD16 mixture in 150mM Na
+ solution before and after six sequences of EIF. (b) Comparison
of the spectral difference between the initial and the ﬁnal spectra (black) with the CD spectrum of HT24 in 150mM Na
+ solution (blue).
Also comparison of the ﬁnal ﬁltrate (red) and LD16 (green) in 150mM Na
+.( c) CD spectra of 20mM HT24 and 20mM T3 mixture before and
after two sequences of EIF. The inset shows the spectral difference between each spectrum and the ﬁnal spectrum (solid line), and the CD spectrum
of T3 (green dash line). (d) Gel assays of T3 (Lane 1), HT24 (Lane 2) and the mixture of them before (Lane 3), and after two sequences of EIF
(Lanes 4 and 5) stained by BMVC for 30s. (e) CD spectra of 20mM LD16 and 20mM T3 mixture before and after two sequences of EIF. The inset
shows the spectral difference between each spectrum and the ﬁnal spectrum. (f) Gel assays of T3 (Lane 1), LD16 (Lane 2) and the mixture of them
before (Lane 3) and after two sequences of EIF (Lanes 4 and 5) stained by BMVC for 30s. (g and h) NMR spectra of DNA sequences of LD16,
HT24 and T3 before and after EIF.
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T3 and LD16 in 150mM Na
+ solution before and after
two sequences of EIF. The results show a large decrease in
the T3 component, but no appreciable change in the
LD16 component after EIF. The gel assays (Figure 4f)
further conﬁrm this ﬁnding. Compared to the separation
of the linear duplex of LD16 from the anti-parallel
G4 structure of HT24, it appears that BMVC-12C-Br
emulsion is more efﬁcient in separating the LD16 from
the parallel G4 structure of T3 after ﬁltration.
We further performed imino proton NMR to examine
whether the NMR spectra of these DNA structures can be
separated after EIF. Figure 4g shows the imino proton
NMR spectra of 100mM LD16, 100mM HT24 and the
mixture of them before and after EIF in 150mM Na
+
solution. It is found that the imino protons are located
at 10.5-12.5ppm for G4 structure and at 12.5–14ppm
for Watson–Crick duplex (48). The spectrum for the
mixture after EIF is almost identical to the spectrum of
LD16, indicating that BMVC-12C-Br EIF is able to
separate LD16 linear duplex from HT24 G4 structure.
Figure 4h shows the NMR spectra for 100mM HT24,
100mM T3 and the mixture of them before and after EIF
in 150mM Na
+solution together with the spectral differ-
ence for the mixture before and after EIF. The NMR
spectrum for the mixture after EIF is quite similar to the
spectrum for HT24. In addition, the spectral difference
for the mixture before and after EIF is very similar to
the spectrum for T3. It appears that BMVC-12C-Br EIF
is also good for the separation of anti-parallel from
parallel G4 structures. Moreover, it is possible to obtain
an individual spectrum of one for DNA in the ﬁltrate
and one for DNA bound by emulsion for further
structural analyses.
Separation of parallel from non-parallel G-quadruplexes
Although the precise structures of HT22 in K
+ solution
remain undetermined, the structures of two modiﬁed
telomeric sequences, Tel24-M (49) and Tel19-M (50)
were analyzed by NMR. Patel et al. (49) have shown
that the hybrid type antiparallel G4 structure is the
major conformation of Tel24-M in K
+ solution, while
Phan et al. [50] have illustrated that the propeller type
parallel G4 structure is predominant conformation of
Tel19-M in K
+ solution. Figure 5a shows the NMR
spectra for 100mM Tel24-M, 100mM Tel19-M and the
mixture of them before and after EIF in 150mM K
+
solution together with the spectral difference before and
after EIF. Both NMR spectra are very consistent with the
documented spectra (49,50). Of importance is that the
spectrum for the mixture after EIF is almost identical to
the spectrum of Tel24-M and the spectral difference
for the mixture before and after EIF is the same as the
spectrum of Tel19-M. The gel assays (Figure 5b) further
conﬁrm this ﬁnding, i.e. a large decrease in the Tel19-M
component, but a slight decrease in the Tel24-M com-
ponent after EIF. It is suggested that BMVC-12C-Br
EIF is able to separate Tel24-M hybrid type from
Tel19-M propeller type G4 structures.
Another pair of G-rich sequences from gene promoter
regions is used to further illustrate this EIF method.
NMR analyses showed that a hybrid type G4 structure
is the major conformation for a sequence of bcl2mid-M
(32) and a parallel type G4 structure is predominated
for a sequence of Myc-2345 (51) in K
+ solution.
Figure 5c shows the NMR spectra for 100mM
bcl2mid-M, 100mM Myc-2345 and the mixture of them
before and after EIF in 150mM K
+ solution together
with the spectral difference before and after EIF. Both
NMR spectra are very consistent with the documented
spectra (32,51). Again, the spectrum after EIF is almost
identical to the spectrum for bcl2mid-M and the spectral
difference before and after EIF is the same as the spectrum
for Myc-2345. The gel assays (Figure 5d) also show a large
decrease in the Myc-2345 component, but only a slight
change in the bcl2mid-M component after EIF. Similar
NMR and gel results were also observed for the separation
of TBA antiparallel G4 structure from Pu24myc parallel
G4 structure in K
+ solution after EIF (data not shown).
These results clearly indicate that this EIF method can
well separate the non-parallel G4 structures from the
parallel G4 structures.
In addition, NMR analysis shows that the two repeated
human telomeric sequence HT12 can form both parallel
and anti-parallel G4 structures in K
+ solution (48).
Figure 5e shows the CD spectra of HT12 in 150mM K
+
solution before and after two sequences of EIF. The large
decrease in the 265nm CD band after the ﬁrst ﬁltration
suggests that parallel G4 structures can be separated after
EIF, as shown in the inset. Moreover, Figure 5f shows the
imino proton NMR of HT12 in 150mM K
+ solution
before and after EIF together with the spectral difference
between them. There are a set of minor peaks and a set of
major peaks in the spectrum before EIF, which are con-
sistent with the previous NMR analysis (48). After EIF,
the minor peaks remained in the ﬁltrate are due to
anti-parallel G4 structure and the major peaks obtained
from the spectral difference are attributed to parallel G4
structure. It is suggested that BMVC-12C-Br emulsion can
separate the antiparallel type from the parallel type
G4 structures formed by the same G-rich sequence.
The parallel G4 structures of HT22 in K
+ solution?
We now are able to verify whether the parallel G4 struc-
ture is a major conformation of HT22 in 150mM K
+
solution. The absence of a large change in the 265nm
CD band and no appreciable difference in the imino
proton NMR spectra after EIF (data not shown) suggest
that the parallel G4 structure is not a major conformation
of HT22 in K
+ solution.
It is found that the human telomere can adopt a parallel
G4 structure in K
+ solution under molecular crowding
conditions by the addition of 40% (w/v) PEG 200
(31,52). Recently, a number of studies showed that PEG
acts as a dehydrating agent than as a crowding agent
(53,54). It is of interest to investigate whether BMVC-
12C-Br emulsion can separate the parallel form after
structural conversion from the non-parallel form under
PEG condition. Figure 6a shows the CD spectra of
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+ solution before and after EIF. (b) Gel assays of Tel19-M (Lane 1), Tel24-M
(Lane 2) and the mixture of them before (Lane 3) and after EIF (Lane 4). (c) NMR spectra of bcl2mid-M and Myc2345 in 150mM K
+ solution
before and after EIF. (d) Gel assays of bcl2mid-M (Lane 1), Myc-2345 (Lane 2), the mixture of them before (Lane 3) and after EIF (Lane 4).
(e) CD and (f) NMR spectra of HT12 in 150mM K
+ solution before and after EIF.
(a)( b)
Figure 6. (a) CD spectra of HT22 in 150mM K
+ solution upon addition of 40% (w/v) PEG 200 before and after two sequences of EIF. The inset
shows spectral difference between each spectrum and the ﬁnal spectrum. (b) NMR spectra of HT22 and upon addition of 50% (v/v) EtOH for
overnight before and after EIF together with their spectral difference.
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+solution and upon adding 40% (w/v)
PEG 200 before and after two sequences of EIF. After
addition of the PEG 200, the appreciable increase in the
265nm CD band together with the decrease in the 295nm
CD band indicates a structural change in HT22. Again,
the signiﬁcant decrease in the 265nm CD band after each
EIF is consistent with the previous results, i.e. the parallel
G4 structure after conversion is selected by the
BMVC-12C-Br emulsion. It further veriﬁes the structural
change from the non-parallel type G4 structure to the
parallel G4 structure of HT22 when a dehydrating agent
exists.
Since PEG is inconvenient for NMR spectrum and has
a high viscosity and a low dielectric constant, Trent et al.
(53) used acetonitrile as a dehydrating agent and
found similar conformational transitions of HT22 in K
+
solution. Here, we use ethanol as a dehydrating agent (55)
because the acetonitrile can damage MCE membrane.
Figure 6b shows the imino proton NMR spectra of
HT22 in 150mM K
+ solution and upon addition of
50% (v/v) ethanol for overnight before and after EIF
together with the spectral difference between them.
The NMR spectra of HT22 in K
+ solution show signiﬁ-
cant changes after addition of ethanol. Considering that
BMVC-12C-Br emulsion has better selectivity to the
parallel structure, it is likely that the spectral difference
characterized by the major signals between 11.1 and
11.3ppm is due to the parallel type G4 structure.
Further study of this difference spectrum may be useful
in determining the precise structure of the converted
conformation of HT22.
High order G4 structures
We now examine whether BMVC-12C-Br emulsion can be
used to separate bcl2mid monomer from the bcl2mid
dimer formed in 150mM K
+ solution. Figure 7a shows
the gel assays of bcl2mid before and after two sequences
of EIF. We found a dramatic decrease in the dimer com-
ponents, but a slight decrease in the monomer component
after EIF. Again, Figure 7b shows a signiﬁcant decrease
in the 265nm CD band after EIF. The 64% loss and 33%
loss of the dimer component in the gel assays correlates
well with the 67% decrease and 33% decrease in the
265nm CD band after two sequences of EIF, indicating
Figure 7. (a) Gel assays of bcl2mid before (Lane 1) and after two sequences of ﬁltration (Lanes 2 and 3). (b) CD spectra of bcl2mid in 150mM K
+
solution before and after two sequences of EIF. The inset shows spectral difference between each spectrum and the ﬁnal spectrum. (c) Ultra
centrifugation of bcl2mid in 150mM K
+ solution before and after EIF and bcl2mid in 5mM K
+ solution. (d) NMR spectra of Bcl2mid in 5mM
K
+ solution and in 150mM K
+ solution before and after EIF together with their spectral difference.
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dimer than monomer of bcl2mid.
Furthermore, sedimentation methods based on ultra-
centrifugation analysis (56,57) are used for the character-
ization of monomer, dimer and high-order structures of
bcl2mid. Figure 7c show the sedimentation results of
bcl2mid in 5mM K
+ solution and bcl2mid in 150mM
K
+ solution before and after EIF. Since molecular
weight of each species can be measured directly by experi-
ment, a major component of bcl2mid monomer is detected
in 5mM K
+ solution, while multiple species including
monomer, dimer and tetramer are found in 150mM K
+
solution, which are consistent with the ﬁndings in gel
assays. After EIF, signiﬁcant decrease of the intermo-
lecular species indicates that BMVC-12C-Br emulsion
selects intermolecular species of bcl2mid and the
complexes are trapped in the membrane. In contrast, no
appreciable difference of the monomer suggests that the
intramolecular species free from emulsion are isolated
in the ﬁltrate.
Figure 7d shows the imino proton NMR spectra of
100mM bcl2mid in 150mM K
+ solution before and after
EIF together with the spectral difference between them.
The spectra presented, the imino region for quadruplex
DNA, are typical of a mixture of several conformations.
Since BMVC-12C-Br EIF can separate intramolecular
from intermolecular G4 structures, a broad envelope
with some ﬁne lines at 11–12ppm in the NMR spectrum
after EIF suggests that at least two different G4 structures
of bcl2mid monomer coexist in a K
+solution. In addition,
a weak broad envelope centered at  10.8ppm in the
difference spectrum is mainly due to multiple intermolecu-
lar species of bcl2mid. This weak broad envelope in the
difference spectrum is further conﬁrmed by using 400mM
bcl2mid in 150mM K
+ solution before and after EIF
(data not shown).
To further compare the bcl2mid monomer obtained
directly from the predominant component of bcl2mid in
5mMK
+ solution (33) and indirectly from the ﬁltrate of
bcl2mid in 150mM K
+solution, Figure 7d also shows an
NMR spectrum of bcl2mid monomer prepared in 5mM
K
+ solution annealed at 95 C and then augmented with
potassium to 150mM, which is very similar to the docu-
mented spectrum (41). Although CD cannot give precise
structures of these G-quadruplexes, it can be used to
distinguish parallel and antiparallel G4 structures based
on their strand orientation (58). The absence of the
295nm CD signal in the difference spectrum suggests
that the parallel type G4 structures are predominated in
the intermolecular conformers of bcl2mid. Such parallel
type G4 structure was found in the Pu22myc dimer (59).
In addition, this EIF method can isolate the non-parallel
type G4 structures in the ﬁltrate from the parallel type G4
structures in the membrane. The broad envelope shown in
the NMR spectrum after EIF suggests that at least two
non-parallel G4 structures coexist in bcl2mid monomer.
Similarly, the broad envelope shown in the difference
spectrum also suggests that multiple parallel G4 structures
co-exist in the intermolecular species of bcl2mid. Thus, the
coexistence of the multiple conformers causes the problem
for determining the structure of each conformer of
bcl2mid.
In summary, we have demonstrated a novel method for
the structural separation of G-quadruplex DNA. This
method combines a methodology for membrane
emulsion/ﬁltration and a lipophilic analogue of BMVC
that can form an oil-in-water emulsion with high
binding afﬁnity to speciﬁc DNA structure. The BMVC-
12C-Br EIF process has been proven to separate linear
duplexes from G4 structures and non-parallel G4 struc-
tures from parallel G4 structures. The spectrum obtained
after EIF treatment is mainly determined by the DNA in
the ﬁltrate and the spectrum obtained from the difference
before and after EIF treatment can be attributed to
the DNA bound by the emulsion. This process provides
information useful in establishing spectrum–structure
correlation. The process can also be used to identify
parallel and non-parallel G4 structures for unknown
G-rich sequences. These data provide ‘proof-of-concept’
evidence for the selective targeting of emulsiﬁed agents to
speciﬁc DNA structure for structural separation. The
general process could have a signiﬁcant impact on this
ﬁeld and others.
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